NCT07446322
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07446322
Title FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Oncolytics Biotech
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Central Alabama Research RECRUITING Homewood Alabama 35209 United States Details
Clinical Research Advisors (Beverly Hills) NOT_YET_RECRUITING Beverly Hills California 90211 United States Details
Clinical Research Advisors (Encino) NOT_YET_RECRUITING Encino California 91316 United States Details
Clinical Research Advisors (Korea Town) NOT_YET_RECRUITING Koreatown California 90020 United States Details
Clinical Research Advisors (Downtown LA) NOT_YET_RECRUITING Los Angeles California 90033 United States Details
Clinical Research Advisors (West Hollywood) NOT_YET_RECRUITING Los Angeles California 90048 United States Details
Clinical Research Advisors (West Covina) NOT_YET_RECRUITING West Covina California 91790 United States Details
Emory Winship Cancer Institute RECRUITING Atlanta Georgia 30302 United States Details
Community Health Network NOT_YET_RECRUITING Indianapolis Indiana 46250 United States Details
Washington University School of Medicine NOT_YET_RECRUITING St Louis Missouri 63110 United States Details
Summit Health Cancer Center RECRUITING Florham Park New Jersey 07932 United States Details
Rutgers Cancer Institute RECRUITING New Brunswick New Jersey 08901 United States Details
Gabrail Cancer Center RECRUITING Canton Ohio 44718 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field